Skip to main content
. 2021 Jun 30;22(13):7054. doi: 10.3390/ijms22137054

Figure 1.

Figure 1

Effects of SNP and/or isoflavones on the viability of primary chondrocytes. (A) The cells were treated with 0.6–1.4 mM SNP for 24 h; (B) The cells were treated with 1–50 μM S-Equol for 24 h; (C) The cells were treated with 1–50 μM S-Equol for 24h in the presence or absence of 0.8 mM SNP for another 24 h; and (D) The cells were treated with 30 μM S-Equol (E), Daidzein (D), Genistein (G), or Biochanin A (B) for 24 h in the absence (control) or presence of 0.8 mM SNP for another 24 h. The results are expressed as the mean ± the S.D. for three separate experiments. * p < 0.05 compared to the untreated control group. # p < 0.05 compared to the SNP treated group.